Tesaro, Inc. (NASDAQ:TSRO) Ratings Summary as of Jun 27, 2018

June 27, 2018 - By Michael Lund

Tesaro, Inc. (NASDAQ:TSRO) Corporate Logo
During 2018 Q1 the big money sentiment increased to 1.14. That’s change of 0.13, from 2017Q4’s 1.01. 41 investors sold all, 58 reduced holdings as Tesaro, Inc. ratio improved. 80 rose stakes while 33 funds acquired stakes. Funds hold 60.57 million shares thus 4.53% more from 2017Q4’s 57.95 million shares.
Oracle Inv Management holds 11.69% in Tesaro, Inc. (NASDAQ:TSRO) or 844,718 shs. The Japan-based Asset Mngmt One Com has invested 0.01% in Tesaro, Inc. (NASDAQ:TSRO). Bnp Paribas Arbitrage Sa stated it has 0% of its capital in Tesaro, Inc. (NASDAQ:TSRO). New York State Common Retirement Fund has invested 0.01% in Tesaro, Inc. (NASDAQ:TSRO). Opus Point Mgmt Ltd Liability Company holds 1.29% or 11,500 shs. Great West Life Assurance Can owns 11,213 shs or 0% of their US capital. Raymond James And Associates accumulated 4,881 shs. Jpmorgan Chase And Com has invested 0% in Tesaro, Inc. (NASDAQ:TSRO). Jasper Ridge Ptnrs Lp stated it has 0.01% in Tesaro, Inc. (NASDAQ:TSRO). 1,401 were accumulated by Daiwa Grp Inc. Qvt Financial L P, New York-based fund reported 6,005 shs. Aperio Gru has invested 0% in Tesaro, Inc. (NASDAQ:TSRO). 622,767 are owned by Retail Bank Of New York Mellon. Nomura accumulated 33,191 shs. Hanson Mcclain holds 0% of its capital in Tesaro, Inc. (NASDAQ:TSRO) for 106 shs.

Tesaro, Inc. had 8 selling transactions and 9 buys since March 1, 2018. This’s net activity of $60.88 million. $8.35 million worth of stock was bought by SANDELL SCOTT D on Friday, March 2. Oliveira Orlando sold $209,640 worth of Tesaro, Inc. (NASDAQ:TSRO) on Thursday, March 8. On Friday, March 2 NEW ENTERPRISE ASSOCIATES 13 LP had bought 116,445 shs worth $6.68M. $307,920 worth of Tesaro, Inc. (NASDAQ:TSRO) was sold by Alleva Lawrence M. $144,501 worth of Tesaro, Inc. (NASDAQ:TSRO) shs were sold by Farmer Joseph L. On Friday, March 2 KERINS PATRICK J also bought $6.68M worth of Tesaro, Inc. (NASDAQ:TSRO).

Tesaro, Inc. (NASDAQ:TSRO) Ratings Coverage

In total 15 analysts cover Tesaro (NASDAQ:TSRO). “Buy” rating has 12, “Sell” are 0, while 3 are “Hold”. (NASDAQ:TSRO) has 80% bullish analysts. 18 are the (NASDAQ:TSRO)’s ratings reports on Jun 27, 2018 according to StockzIntelligence Inc. On Wednesday, May 2 the company was maintained by Argus Research. On Wednesday, February 28 the stock has “Buy” rating by Wells Fargo. On Friday, May 4 the stock of Tesaro, Inc. (NASDAQ:TSRO) has “Buy” rating given by Bank of America. On Tuesday, March 27 the firm has “Buy” rating by Wedbush given. On Thursday, February 22 the rating was upgraded by Evercore to “Outperform”. On Thursday, May 31 the company was maintained by Citigroup. The company rating was maintained by Credit Suisse on Friday, May 4. The stock rating was maintained by Cowen & Co with “Hold” on Wednesday, February 28. On Wednesday, February 28 Leerink Swann maintained Tesaro, Inc. (NASDAQ:TSRO) rating. Leerink Swann has “Buy” rating and $105.0 target. On Wednesday, January 3 Guggenheim maintained the shares of TSRO in report with “Buy” rating. Listed here are Tesaro, Inc. (NASDAQ:TSRO) PTs and latest ratings.

31/05/2018 Broker: Citigroup Rating: Buy New Target: $100.0000 Maintain
07/05/2018 Broker: Lake Street Rating: Buy New Target: $80.0000 Maintain
04/05/2018 Broker: Bank of America Old Rating: Buy New Rating: Buy Old Target: $94 New Target: $88 Maintain
04/05/2018 Broker: Credit Suisse Old Rating: Outperform New Rating: Outperform Old Target: $141 New Target: $128 Maintain
04/05/2018 Broker: Citigroup Old Rating: Buy New Rating: Buy Old Target: $102 New Target: $100 Maintain
04/05/2018 Broker: H.C. Wainwright Rating: Buy New Target: $104.0000 Maintain
02/05/2018 Broker: Argus Research Old Rating: Buy New Rating: Buy Old Target: $154 New Target: $110 Maintain
16/04/2018 Broker: Piper Jaffray Rating: Hold Maintain
27/03/2018 Broker: Wedbush Rating: Buy New Target: $76.0000 Maintain
28/02/2018 Broker: Cowen & Co Rating: Hold New Target: $66.0 Maintain

Ticker’s shares touched $43.5 during the last trading session after 0.25% change.Tesaro, Inc. has volume of 278,840 shares. Since June 27, 2017 TSRO has declined 66.21% and is downtrending. TSRO underperformed the S&P500 by 78.78%.

Tesaro, Inc., an oncology-focused biopharmaceutical company, identifies, acquires, develops, and commercializes cancer therapeutics and oncology supportive care products in the United States.The firm is worth $2.39 billion. It markets Rolapitant, a neurokinin-1, or NK-1, receptor antagonist for the prevention of chemotherapy induced nausea and vomiting under the VARUBI brand name.Currently it has negative earnings. The firm is also developing Niraparib, an orally active and potent poly polymerase inhibitor, which is in various clinical trials to treat ovarian or breast cancers.

For more Tesaro, Inc. (NASDAQ:TSRO) news published recently go to: Seekingalpha.com, Fool.com, Seekingalpha.com, Nasdaq.com or Seekingalpha.com. The titles are as follows: “Tesaro: Consider Calls” published on June 19, 2018, “ASCO Conference Preview: Here’s What Biotech Investors Need to Watch” on May 31, 2018, “Tesaro: Can Upcoming Catalyst Bring Fortune To This Unpopular Company?” with a publish date: June 01, 2018, “Why Winnebago Industries, Synaptics, and Tesaro Jumped Today” and the last “Tesaro: Was That The Bottom?” with publication date: June 25, 2018.

Tesaro, Inc. (NASDAQ:TSRO) Institutional Investors Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.




Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: